Phase II trial of weekly docetaxel, vinorelbine, and trastuzumab in the first-line treatment of patients (pts) with HER2-positive metastatic breast cancer (MBC)
2008 ◽
Vol 26
(15_suppl)
◽
pp. 1032-1032
◽
Keyword(s):
Phase Ii
◽
2012 ◽
2007 ◽
Vol 5
(4)
◽
pp. 221-222